High-Throughput Virtual Screening of Small Molecule Inhibitors for SARS-CoV-2 Protein Targets with Deep Fusion Models

• URL: http://arxiv.org/abs/2104.04547v1
• Date: Fri, 9 Apr 2021 18:18:26 GMT
• Title: High-Throughput Virtual Screening of Small Molecule Inhibitors for SARS-CoV-2 Protein Targets with Deep Fusion Models
• Authors: Garrett A. Stevenson, Derek Jones, Hyojin Kim, W. F. Drew Bennett, Brian J. Bennion, Monica Borucki, Feliza Bourguet, Aidan Epstein, Magdalena Franco, Brooke Harmon, Stewart He, Max P. Katz, Daniel Kirshner, Victoria Lao, Edmond Y. Lau, Jacky Lo, Kevin McLoughlin, Richard Mosesso, Deepa K. Murugesh, Oscar A. Negrete, Edwin A. Saada, Brent Segelke, Maxwell Stefan, Marisa W. Torres, Dina Weilhammer, Sergio Wong, Yue Yang, Adam Zemla, Xiaohua Zhang, Fangqiang Zhu, Felice C. Lightstone, Jonathan E. Allen
• Abstract summary: Over 500 million small molecules were screened against four protein structures from the novel coronavirus (SARS-CoV-2), which causes COVID-19. Three enhancements to Deep Fusion were made in order to evaluate more than 5 billion docked poses on SARS-CoV-2 protein targets.
• Score: 3.8075853084146023
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Structure-based Deep Fusion models were recently shown to outperform several physics- and machine learning-based protein-ligand binding affinity prediction methods. As part of a multi-institutional COVID-19 pandemic response, over 500 million small molecules were computationally screened against four protein structures from the novel coronavirus (SARS-CoV-2), which causes COVID-19. Three enhancements to Deep Fusion were made in order to evaluate more than 5 billion docked poses on SARS-CoV-2 protein targets. First, the Deep Fusion concept was refined by formulating the architecture as one, coherently backpropagated model (Coherent Fusion) to improve binding-affinity prediction accuracy. Secondly, the model was trained using a distributed, genetic hyper-parameter optimization. Finally, a scalable, high-throughput screening capability was developed to maximize the number of ligands evaluated and expedite the path to experimental evaluation. In this work, we present both the methods developed for machine learning-based high-throughput screening and results from using our computational pipeline to find SARS-CoV-2 inhibitors.

Related papers

• TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs [49.69047720285225]
  We propose a novel topological approach that explicitly extracts multi-scale topological structures to better approximate breast parenchymal structures. We empirically validate emphTopoTxR using the VICTRE phantom breast dataset. Our qualitative and quantitative analyses suggest differential topological behavior of breast tissue in treatment-na"ive imaging.
  arXiv  Detail & Related papers  (2024-11-05T19:35:10Z)
• Manifold-Constrained Nucleus-Level Denoising Diffusion Model for Structure-Based Drug Design [81.95343363178662]
  atoms must maintain a minimum pairwise distance to avoid separation violations. NucleusDiff models the interactions between atomic nuclei and their surrounding electron clouds by enforcing the distance constraint. It reduces violation rate by up to 1000% and enhances binding affinity by up to 22.16%, surpassing state-of-the-art models for structure-based drug design.
  arXiv  Detail & Related papers  (2024-09-16T08:42:46Z)
• From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph-Based Deep Learning [40.83037811977803]
  Dynaformer is a graph-based deep learning model developed to predict protein-ligand binding affinities. It exhibits state-of-the-art scoring and ranking power on the CASF-2016 benchmark dataset. In a virtual screening on heat shock protein 90 (HSP90), 20 candidates are identified and their binding affinities are experimentally validated.
  arXiv  Detail & Related papers  (2022-08-19T14:55:12Z)
• Benchmarking Machine Learning Robustness in Covid-19 Genome Sequence Classification [109.81283748940696]
  We introduce several ways to perturb SARS-CoV-2 genome sequences to mimic the error profiles of common sequencing platforms such as Illumina and PacBio. We show that some simulation-based approaches are more robust (and accurate) than others for specific embedding methods to certain adversarial attacks to the input sequences.
  arXiv  Detail & Related papers  (2022-07-18T19:16:56Z)
• LIMO: Latent Inceptionism for Targeted Molecule Generation [14.391216237573369]
  We present Latent Inceptionism on Molecules (LIMO), which significantly accelerates molecule generation with an inceptionism-like technique. Comprehensive experiments show that LIMO performs competitively on benchmark tasks. One of our generated drug-like compounds has a predicted $K_D$ of $6 cdot 10-14$ M against the human estrogen receptor.
  arXiv  Detail & Related papers  (2022-06-17T21:05:58Z)
• Benchmarking Deep Graph Generative Models for Optimizing New Drug Molecules for COVID-19 [11.853524110656991]
  Design of new drug compounds with target properties is a key area of research in generative modeling. We present a small drug molecule design pipeline based on graph-generative models and a comparison study of two state-of-the-art graph generative models for designing COVID-19 targeted drug candidates.
  arXiv  Detail & Related papers  (2021-02-09T17:49:26Z)
• Designing a Prospective COVID-19 Therapeutic with Reinforcement Learning [50.57291257437373]
  SARS-CoV-2 pandemic has created a global race for a cure. One approach focuses on designing a novel variant of the human angiotensin-converting enzyme 2 (ACE2) We formulate a novel protein design framework as a reinforcement learning problem.
  arXiv  Detail & Related papers  (2020-12-03T07:35:38Z)
• PaccMann$^{RL}$ on SARS-CoV-2: Designing antiviral candidates with conditional generative models [2.0750380105212116]
  With the fast development of COVID-19 into a global pandemic, scientists around the globe are desperately searching for effective antiviral therapeutic agents. We propose a deep learning framework for conditional de novo design of antiviral candidate drugs tailored against given protein targets.
  arXiv  Detail & Related papers  (2020-05-27T11:30:15Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)
• Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts [80.69440684790925]
  DeepRelations is a physics-inspired deep relational network with intrinsically explainable architecture. It shows superior interpretability to the state-of-the-art. It boosts the AUPRC of contact prediction 9.5, 16.9, 19.3 and 5.7-fold for the test, compound-unique, protein-unique, and both-unique sets.
  arXiv  Detail & Related papers  (2019-12-29T00:14:07Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.